Efficacy News and Research

RSS
PolyMedix commences PMX-60056 Phase 2 clinical trial in patients undergoing PCI

PolyMedix commences PMX-60056 Phase 2 clinical trial in patients undergoing PCI

Repligen third quarter total revenue increases 26% to $7,068,000

Repligen third quarter total revenue increases 26% to $7,068,000

QLT's Phase II olopatadine punctal plug delivery system trial demonstrates safety in allergic conjunctivitis patients

QLT's Phase II olopatadine punctal plug delivery system trial demonstrates safety in allergic conjunctivitis patients

Research findings highlight potential for noninvasive MSC delivery to treat Parkinson disease

Research findings highlight potential for noninvasive MSC delivery to treat Parkinson disease

Humira and Enbrel have best overall clinical profile for treatment of moderate to severe psoriasis: Survey

Humira and Enbrel have best overall clinical profile for treatment of moderate to severe psoriasis: Survey

Karo Bio fourth quarter net loss increases to MSEK 50.1

Karo Bio fourth quarter net loss increases to MSEK 50.1

Circassia acquires global rights to novel topical therapeutic for psoriasis and atopic dermatitis

Circassia acquires global rights to novel topical therapeutic for psoriasis and atopic dermatitis

ACE: Hula hooping workouts offer substantial and positive results

ACE: Hula hooping workouts offer substantial and positive results

Novel technique could speed up the development of peptide-based drugs against cancer

Novel technique could speed up the development of peptide-based drugs against cancer

Pervasis' Vascugel granted Fast Track review status for prevention of hemodialysis access failure in ESRD patients

Pervasis' Vascugel granted Fast Track review status for prevention of hemodialysis access failure in ESRD patients

NMS Labs launches unique test for Methotrexate

NMS Labs launches unique test for Methotrexate

ASBP concerned over FDA rejection of Contrave drug

ASBP concerned over FDA rejection of Contrave drug

Rib-X commences Phase 2b trial to assess delafloxacin, linezolid, vancomycin for treatment of ABSSSI

Rib-X commences Phase 2b trial to assess delafloxacin, linezolid, vancomycin for treatment of ABSSSI

Reducing the cardiovascular disease gender gap

Reducing the cardiovascular disease gender gap

Total flu cover with one shot

Total flu cover with one shot

Study shows dogs can be trained to detect PCa by smelling urine

Study shows dogs can be trained to detect PCa by smelling urine

Cleveland Clinic, JumpStart Ventures invest $500,000 in SironRX Therapeutics

Cleveland Clinic, JumpStart Ventures invest $500,000 in SironRX Therapeutics

Transition reports second quarter 2011 net income of $24.28M vs. $6.05M net loss for second quarter 2010

Transition reports second quarter 2011 net income of $24.28M vs. $6.05M net loss for second quarter 2010

Study on non-surgical approach for treatment of liver hydatidosis

Study on non-surgical approach for treatment of liver hydatidosis

Study reports significant decline in second-generation medication use for dementia

Study reports significant decline in second-generation medication use for dementia

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.